The ABPI opened an office in Edinburgh at the reconvening of the Scottish Parliament in 1999. The ABPI Scotland team works to represent the interests of our member companies to stakeholders here in Scotland.
We ensure that bodies such as the Scottish Government and NHS Scotland are kept informed about the issues affecting our sector and we also work closely with member companies to support their relations ensuring that they are supported in navigating the landscape of a devolved Scotland within the United Kingdom.
Fraser of Allander Institute Report
The pharmaceutical sector plays an important role in the Scottish economy. This report, by the Fraser of Allander Institute (FAI) at the University of Strathclyde, looks at the value of the sector.Download the report
What is the value of the pharmaceutical industry to Scotland?
The wider pharmaceutical sector itself employs 5,600 full-time equivalent (FTE) jobs and, once spill over effects are accounted for, generates £1.8bn of Gross Value Added in Scotland.
On its own, the manufacturing of pharmaceuticals employs around 4,000 people, with significant employment in rural areas.
The sector has complex supply chains and every pound of value created by the pharmaceutical sector, in turn, generates further value and jobs.
For every 10 jobs in the wider pharmaceutical industry a further 17 are supported in the wider economy.
ABPI Scotland publications
The Economic Contribution of the Pharmaceuticals Sector in Scotland
The pharmaceutical sector plays an important role in the Scottish economy. This report, by the Fraser of Allander Institute (FAI) at the University of Strathclyde, looks at the value of the sector.
ABPI Scotland 2021 Manifesto for Medicine
Our manifesto outlining a number of actions for the next Scottish Government to take that will improve the nation’s collective health and wealth.
ABPI Scottish Cancer Recovery Roundtable
The COVID-19 pandemic has brought challenges to the way cancer treatments and clinical trials are delivered across Scotland and it is clear that collaboration will be required to ensure care returns to pre-pandemic levels.
ABPI Scotland Jargon Buster 2021
Creating an NHS ‘fit for the future’ is about embracing cutting edge technology so all patients in Scotland have access to world-class standards of care and disease prevention. We hope that this health jargon buster will help you translate the confusing array of acronyms used in the healthcare field.
The future burden of CHD and diabetes in Scotland: The value of healthcare innovation
2005 report says NHS Scotland could save thousands of lives, avoid 80,000 bed days and more efficiently use health resources. Health innovation has an important part to play in managing the burden of diabetes and CHD in Scotland; saving and improving the quality of patients lives, according to an economic report published in 2005.
Report of a survey of service provision for patients with RA and associated conditions
This is the report of a survey of service provision, and the opinions of those delivering services, for patients with RA and associated conditions. It is a snapshot of this area of patient care that is felt by many of those involved to have a lower priority in terms of policy and resources than it should.
Contribution of pharma-related businesses to the Scottish economy
This is the third in a series of independent reports commissioned by ABPI Scotland with Ewen Peters’ Associates (EPA) which estimates the economic impact of “pharma-related businesses” in Scotland, both directly and more widely.
ABPI Scotland: Medicines for Scottish life
Health outcomes in Scotland are improving. Cancer survival, for instance – which is heavily dependent on oncology medicines – has improved by 18 per cent for men and 15 per cent for women between 1983 and 2007.
ABPI Scotland Staff
ABPI Scotland is led by Alison Culpan, ABPI Scotland Director, with support from Helen Reilly, Public Affairs Manager and Claire Headspeath, Team Co-ordinator.
How to find us
4 Crichton's Close
+44 (0) 131 523 0497